Skip to content
healthcare.dev

Guaifenesin and Codeine Phosphate

NDC 0121-1775, Guaifenesin and Codeine Phosphate, solution, from PAI Holdings, LLC.

Product NDC
0121-1775
Status
Listed
Labeler
PAI Holdings, LLC
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0121-1775 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN100 mg/5mL
  • CODEINE PHOSPHATE10 mg/5mL

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Full Opioid Agonists [MoA]; Increased Respiratory Secretions [PE]; Opioid Agonist [EPC]

Package NDCNDC-11Package
0121-1775-000012117750010 TRAY in 1 CASE (0121-1775-00) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-1775-05)
0121-1775-100012117751010 TRAY in 1 CASE (0121-1775-10) / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE
0121-1775-40001211775404 TRAY in 1 CASE (0121-1775-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-1775-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0121-1775 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0121-1775 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0121-1775. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.